Target intelligence / Profile preview

Uropathogenic Escherichia coli SOS response and SulA-mediated filamentation pathway (UPEC SOS-SulA pathway)

Target
UPEC SOS-SulA pathway
Molecular classification
Signaling pathway, DNA repair system, Cell cycle regulation
01

Overview

The Uropathogenic Escherichia coli (UPEC) SOS response and SulA-mediated filamentation pathway is a critical survival mechanism used by bacteria during urinary tract infections (Justice et al., 2006, PNAS). Triggered by DNA damage—often caused by host immune defenses like reactive oxygen species or antibiotics such as fluoroquinolones—the SOS response involves the activation of RecA, which facilitates the self-cleavage of the repressor LexA (Simmons et al., 2008, Molecular Cell). This derepression leads to the expression of over 40 genes, including sulA, which encodes a protein that binds to and inhibits FtsZ, the primary protein responsible for bacterial cell division (Janion, 2008, Acta Biochimica Polonica). The resulting filamentation allows UPEC to avoid phagocytosis by neutrophils and escape from intracellular bacterial communities (IBCs) within the bladder epithelium (Justice et al., 2004, Journal of Clinical Investigation). Targeting this pathway, particularly through the inhibition of RecA or LexA, is an emerging strategy to reduce bacterial virulence and prevent the development of antibiotic resistance (Bellio et al., 2017, Frontiers in Microbiology).

Other names
SOS responseSulA-mediated filamentationUPEC DNA damage responseLexA-RecA regulatory circuitBacterial SOS system
02

Mechanism of action

Inhibition of RecA-mediated LexA cleavage to prevent SOS induction; direct inhibition of SulA binding to FtsZ to prevent filamentation; or induction of the pathway via DNA-damaging agents like fluoroquinolones (Bellio et al., 2017, Frontiers in Microbiology).

03

Biological functions

DNA repairCell cycle arrestStress responseBacterial filamentationImmune evasionHorizontal gene transfer regulation
04

Disease associations

InfectionUrinary tract infection (UTI)Antibiotic resistanceSepsis
05

Safety considerations

Disruption of the commensal gut and vaginal microbiomeSelection pressure for alternative resistance mechanismsPotential toxicity of experimental RecA/LexA inhibitorsRisk of enhancing horizontal gene transfer if partially inhibited
06

Interacting drugs

Ciprofloxacin

5 more in the full profile.

07

Biomarkers

SulA protein levelsRecA expressionLexA cleavage productsBacterial filamentation indexumuDC expression

Beyond the preview

Go deeper on Uropathogenic Escherichia coli SOS response and SulA-mediated filamentation pathway (UPEC SOS-SulA pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uropathogenic Escherichia coli SOS response and SulA-mediated filamentation pathway (UPEC SOS-SulA pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call